Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1

Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas

(2020) William D. Tap et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States

(2020) Seth M. Pollack et al.   Cancer Medicine

First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1

(2019) Amit Mahipal et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1

(2019) Neeta Somaiah et al.   CLINICAL CANCER RESEARCH

Recent advances and application of PD-1 blockade in sarcoma

(2019) Wenli Zuo et al.   OncoTargets and Therapy

Synovial Sarcoma: Current Concepts and Future Perspectives

(2018) Silvia Stacchiotti et al.   JOURNAL OF CLINICAL ONCOLOGY

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives

(2018) Remy Thomas et al.   Frontiers in Immunology

Perspective: cancer vaccines in the era of immune checkpoint blockade

(2018) Jonathan Cebon   MAMMALIAN GENOME

Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review

(2018) Richard Riedel et al.   Cancers

First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma Patient

(2017) Seth M. Pollack et al.   JOURNAL OF IMMUNOTHERAPY

LV305, a dendritic cell-targeting integration-deficient ZVex TM -based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response

(2016) Tina Chang Albershardt et al.   Molecular Therapy-Oncolytics

Managing Liposarcomas: Cutting Through the Fat

(2016) Gulam A. Manji et al.   Journal of Oncology Practice

Cancer vaccines

(2015) L. H. Butterfield   BMJ-British Medical Journal

Cancer vaccines

(2015) L. H. Butterfield   BMJ-British Medical Journal

Localized and metastatic myxoid/round cell liposarcoma

(2013) Aviad Hoffman et al.   CANCER

Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements

(2013) M. Nishino et al.   CLINICAL CANCER RESEARCH

Soft tissue sarcoma subtypes exhibit distinct patterns of acquired uniparental disomy

(2012) Musaffe Tuna et al.   BMC Medical Genomics

NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma

(2012) Seth M. Pollack et al.   CANCER

Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005

(2009) Iyad Sultan et al.   CANCER

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

(2009) J. D. Wolchok et al.   CLINICAL CANCER RESEARCH

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER